APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms

Jean L Mbisa1, Wei Bu, Vinay K Pathak

  • 1HIV Drug Resistance Program, National Cancer Institute at Frederick, P.O. Box B, Building 535, Room 334, Frederick, MD 21702-1201, USA.

Journal of Virology
|March 12, 2010
PubMed

Insights

APOBEC3F (A3F) and APOBEC3G (A3G) inhibit HIV-1 replication by mutating viral DNA. A3F is more potent than A3G at blocking viral DNA integration through distinct mechanisms involving DNA processing and binding affinity.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Background:

  • APOBEC3F (A3F) and APOBEC3G (A3G) are host restriction factors that inhibit HIV-1 replication.
  • Their antiviral activity involves cytidine deamination, leading to lethal mutations in the viral genome.
  • Previous research showed A3G blocks viral DNA transfer and provirus establishment.

Purpose of the Study:

  • To investigate if A3F interferes with HIV-1 provirus formation similarly to A3G.
  • To compare the mechanisms by which A3F and A3G inhibit HIV-1 proviral DNA integration.
  • To determine the role of the catalytic domain and DNA binding affinity in the distinct functions of A3F and A3G.

Main Methods:

  • Southern blot analysis to examine viral cDNA processing.
  • Assessing inhibition of viral DNA synthesis and integration.
  • Evaluating the impact of functional catalytic domains on antiviral activity.
  • Measuring binding affinity of A3F and A3G to viral DNA templates.

Main Results:

  • Both A3F and A3G inhibit HIV-1 DNA synthesis and integration, with A3F being more potent in preventing integration.
  • A3G causes a 6-bp extension at the 3'-LTR U5 end, hindering integration.
  • A3F inhibits integration by reducing 3' processing at both U5 and U3 ends.
  • A functional C-terminal catalytic domain is more critical for A3G than A3F.
  • A3F exhibits greater binding affinity for viral 3'-LTR dsDNA than A3G.

Conclusions:

  • A3F and A3G employ distinct mechanisms to prevent HIV-1 DNA integration.
  • Differences in target specificity and/or dsDNA binding affinity contribute to their distinct antiviral functions.
  • A3F is a more potent inhibitor of HIV-1 provirus formation than A3G due to its unique mechanism of action.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...